Kothari Ferment.

Which are the latest news on Kothari Ferment.?

Why is Kothari Fermentation & Biochem Ltd falling/rising?

As of 05-Sep, Kothari Fermentation & Biochem Ltd's stock price is at 42.19, reflecting a decline of 2.34%. The stock is underperforming its sector and has shown consistent downward trends over the past week and month, despite increased investor participation.

As of 05-Sep, Kothari Fermentation & Biochem Ltd's stock price is falling, currently at 42.19, which reflects a decrease of 1.01 or 2.34%. This decline is evident in the stock's performance today, where it underperformed its sector by 1.44%. Over the past week, the stock has seen a slight decrease of 0.31%, and over the past month, it has dropped by 6.27%, indicating a consistent downward trend.<BR><BR>In terms of moving averages, the stock is currently higher than its 200-day moving average but lower than its 5-day, 20-day, 50-day, and 100-day moving averages, suggesting that while it may have some long-term strength, it is struggling in the short to medium term. Additionally, despite a rise in investor participation, with delivery volume increasing by 148.1% against the 5-day average, the overall market sentiment appears to be negative, as reflected in the year-to-date decline of 3.01% compared to the Sensex's decline of 10.21%. <BR><BR>Overall, the combination of underperformance against benchmarks, negative short-term trends, and the current price drop contribute to the stock's falling status.

Who are in the management team of Kothari Ferment.?

The management team of Kothari Ferment includes Pramod Kumar Kothari (Chairman & Managing Director), Kavita Devi Kothari (Whole-time Director), Siddhant Kothari (Whole-time Director), and independent directors Hemedra Pat Singh Dugar, Piyush Kumar Goel, and Rajiv Agarwal, along with Silky Gupta (Company Secretary & Compliance Officer). They oversee the company's operations and strategic direction.

The management team of Kothari Ferment includes the following individuals:<BR><BR>1. **Pramod Kumar Kothari** - Chairman & Managing Director<BR>2. **Kavita Devi Kothari** - Whole-time Director<BR>3. **Hemedra Pat Singh Dugar** - Independent Director<BR>4. **Piyush Kumar Goel** - Independent Director<BR>5. **Siddhant Kothari** - Whole-time Director<BR>6. **Silky Gupta** - Company Secretary & Compliance Officer<BR>7. **Rajiv Agarwal** - Independent Director<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

What does Kothari Ferment. do?

Kothari Fermentation & Biochem Ltd manufactures yeast and its derivatives in the FMCG sector. As of June 2026, it reported net sales of 30 Cr and a market cap of INR 63 Cr.

Overview:<BR>Kothari Fermentation & Biochem Ltd is a manufacturer of yeast and its derivatives, operating in the FMCG industry within the micro-cap market segment.<BR><BR>History:<BR>Incorporated in 1990, Kothari Fermentation & Biochem Ltd was promoted by Motilal Kothari and his Associates. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 30 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 0 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 63 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 44 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.87 <BR>Return on Equity: -3.95% <BR>Price to Book: 1.19 <BR><BR>Contact Details:<BR>Address: 16 Community Centre, 1st Floor Saket New Delhi New Delhi : 110017 <BR>Tel: 91-011-26517665/26850004/40590944 <BR>Email: info@kothariyeast.in <BR>Website: http://www.kothariyeast.in

Who are the peers of the Kothari Ferment.?

Kothari Ferment's peers include Yuvraaj Hygiene, Team24 Consumer, Nakoda Group, Virat Crane Inds, Tanvi Foods, Oceanic Foods, Artemis ADR Mark, and Omfurn India. Notably, Nakoda Group has the highest 1-year return at 36.53%, while Yuvraaj Hygiene has the lowest at -51.79%.

Peers: The peers of Kothari Ferment. are Yuvraaj Hygiene, Team24 Consumer, Nakoda Group, Virat Crane Inds, Tanvi Foods, Oceanic Foods, Artemis ADR Mark, Omfurn India.<BR><BR>Quality Snapshot: Excellent management risk is observed at Omfurn India, while Average management risk is found at Yuvraaj Hygiene and Oceanic Foods, and the rest have Below Average management risk. Growth is Excellent at Team24 Consumer, Good at Yuvraaj Hygiene, and the rest have Below Average growth. Capital Structure is Excellent at Virat Crane Inds, Good at Artemis ADR Mark, Average at Yuvraaj Hygiene and Oceanic Foods, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: Nakoda Group has the highest 1-year return at 36.53%, while Yuvraaj Hygiene has the lowest at -51.79%. Kothari Ferment.'s 1-year return is -13.80%, which is better than Yuvraaj Hygiene but worse than Nakoda Group. Additionally, peers such as Team24 Consumer and Oceanic Foods have negative six-month returns.

How big is Kothari Ferment.?

As of 31st August, Kothari Fermentation & Biochem Ltd has a market capitalization of 63.00 Cr and reported Net Sales of 118.79 Cr, with a Net Profit loss of 2.13 Cr over the latest four quarters.

As of 31st August, Kothari Fermentation & Biochem Ltd has a market capitalization of 63.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Kothari Fermentation reported Net Sales of 118.79 Cr. However, the company experienced a Net Profit loss of 2.13 Cr during the same period.<BR><BR>The latest annual period for the balance sheet is March 2025, where Shareholder's Funds amounted to 56.57 Cr and Total Assets were reported at 127.92 Cr.

Should I buy, sell or hold Kothari Fermentation & Biochem Ltd?

Are Kothari Fermentation & Biochem Ltd latest results good or bad?

Kothari Fermentation & Biochem Ltd's latest results show a return to profitability with a net profit of ₹1.27 crore in Q4 FY26, but revenue growth is stagnant at just 0.90% year-on-year, raising concerns about the sustainability of this recovery amid high financial leverage and a significant stock price decline. Investors should approach with caution due to the company's fragile financial health.

Kothari Fermentation & Biochem Ltd's latest results present a mixed picture. On one hand, the company reported a net profit of ₹1.27 crore for Q4 FY26, a significant improvement from a loss of ₹0.38 crore in the previous quarter. This marks a positive turnaround in profitability after three consecutive quarters of losses. Additionally, the operating margin improved to 8.96%, up from 7.45% in the prior quarter.<BR><BR>However, the revenue growth remains concerning, with only a 0.90% increase year-on-year, indicating stagnation in sales. The company has faced significant challenges over the past year, reflected in a dramatic 46.70% decline in its stock price, which has underperformed the broader FMCG sector.<BR><BR>Overall, while the return to profitability in Q4 is a positive development, the underlying issues such as weak revenue growth, high financial leverage, and poor return on equity raise questions about the sustainability of this recovery. Investors should be cautious, as the company's financial health remains fragile and its future performance uncertain.

When is the next results date for Kothari Fermentation & Biochem Ltd?

The next results date for Kothari Fermentation & Biochem Ltd is 29 May 2026.

The next results date for Kothari Fermentation & Biochem Ltd is scheduled for 29 May 2026.

Is Kothari Ferment. overvalued or undervalued?

As of December 2, 2025, Kothari Ferment. is considered overvalued with a PE ratio of -24.53 and an EV to EBITDA of 12.35, showing poor performance with a 43.93% decline in stock price compared to the Sensex's 6.09% increase, despite having a lower PE ratio than peers like Hindustan Unilever and Nestle India.

As of 2 December 2025, Kothari Ferment. has moved from an attractive to a fair valuation grade. The company appears to be overvalued based on its current metrics. Key ratios include a PE ratio of -24.53, an EV to EBITDA of 12.35, and a ROCE of 2.23%. <BR><BR>In comparison to its peers, Kothari Ferment. stands out with a significantly lower PE ratio than Hindustan Unilever at 55.03 and Nestle India at 81.19, both of which are categorized as very expensive. Additionally, while Kothari's EV to EBITDA ratio is 12.35, it remains more favorable than many peers, yet the overall valuation suggests it does not justify its current price of 44.80, especially given its poor stock performance relative to the Sensex over the past year, where it has declined by 43.93% compared to the Sensex's 6.09% increase.

How has been the historical performance of Kothari Ferment.?

Kothari Ferment's historical performance shows a recovery in Mar'25, with net sales rising to 114.23 Cr and operating profit improving to 11.87 Cr, compared to previous losses. Total assets and liabilities decreased, while cash flow from operations increased to 10.00 Cr.

Answer:<BR>The historical performance of Kothari Ferment shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Kothari Ferment's net sales increased from 108.88 Cr in Mar'24 to 114.23 Cr in Mar'25, following a dip in Mar'23. Total operating income also rose to 114.23 Cr in Mar'25 from 108.88 Cr in the previous year. However, the total expenditure decreased slightly from 103.73 Cr in Mar'24 to 102.36 Cr in Mar'25. Operating profit, excluding other income, improved significantly to 11.87 Cr in Mar'25 from 5.15 Cr in Mar'24, while profit before tax turned positive at 1.94 Cr after a loss of 3.93 Cr in the prior year. Profit after tax also recovered to 0.81 Cr in Mar'25 from a loss of 4.91 Cr in Mar'24. The company's total assets decreased from 132.13 Cr in Mar'24 to 127.92 Cr in Mar'25, and total liabilities also fell from 132.13 Cr to 127.92 Cr during the same period. Cash flow from operating activities showed an increase to 10.00 Cr in Mar'25 from 8.00 Cr in Mar'24, while cash flow from investing activities improved as well, reflecting a less negative outflow. Overall, Kothari Ferment's financial performance in Mar'25 indicates a recovery from previous losses, with improvements in sales, profits, and cash flow.

What is the technical trend for Kothari Ferment.?

As of June 2, 2025, Kothari Ferment's technical trend is mildly bearish, influenced by bearish daily moving averages and a mildly bearish monthly MACD, despite some bullish indicators on the weekly charts.

As of 2 June 2025, the technical trend for Kothari Ferment has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD indicates a mildly bearish stance. Moving averages on the daily time frame are bearish, and the Bollinger Bands show a bearish trend on the monthly chart. The KST is bullish on the weekly but mildly bearish on the monthly, while Dow Theory presents a mildly bearish outlook on the weekly and mildly bullish on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the bearish daily moving averages and the monthly MACD.

Who are the top shareholders of the Kothari Ferment.?

The top shareholders of Kothari Ferment include Siddhant Kothari with 24.85%, individual investors with 25.93%, and the highest public shareholder, Dheeraj Kumar Lohia, at 1.47%. There are no mutual funds or foreign institutional investors involved.

The top shareholders of Kothari Ferment include the promoters, with Siddhant Kothari holding the highest stake at 24.85%. Individual investors collectively hold 25.93% of the shares. The highest public shareholder is Dheeraj Kumar Lohia, who owns 1.47% of the company. Notably, there are no mutual funds or foreign institutional investors holding shares in the company.

Has Kothari Ferment. declared dividend?

No Dividend History Available